ID: ALA158681

Max Phase: Preclinical

Molecular Formula: C11H10N4O3

Molecular Weight: 246.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=Nc1c(O)nc(O)nc1NCc1ccccc1

Standard InChI:  InChI=1S/C11H10N4O3/c16-10-8(15-18)9(13-11(17)14-10)12-6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,12,13,14,16,17)

Standard InChI Key:  SRJDHCUJXVCZRL-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.23Molecular Weight (Monoisotopic): 246.0753AlogP: 1.90#Rotatable Bonds: 4
Polar Surface Area: 107.70Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.70CX Basic pKa: CX LogP: 3.24CX LogD: 3.24
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.71Np Likeness Score: -0.76

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source